Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer. - Wikidata - awgldk - TriplyDB

Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer.

Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer.

http://www.wikidata.org/entity/Q36149220

about

RASSF tumor suppressor gene family: biological functions and regulation BSPAT: a fast online tool for DNA methylation co-occurrence pattern analysis based on high-throughput bisulfite sequencing data.Genome-wide and gene-specific epigenomic platforms for hepatocellular carcinoma biomarker development trials.Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas.Differential promoter methylation of kinesin family member 1a in plasma is associated with breast cancer and DNA repair capacity RUNX3 site-specific hypermethylation predicts papillary thyroid cancer recurrence.Lack of Correlation between Aberrant p16, RAR-β2, TIMP3, ERCC1, and BRCA1 Protein Expression and Promoter Methylation in Squamous Cell Carcinoma Accompanying Candida albicans-Induced Inflammation RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis.Analysis of BRAF(V600E) mutation and DNA methylation improves the diagnostics of thyroid fine needle aspiration biopsies.Diagnosis of thyroid cancer: state of art.Transcription control of DAPK.Evaluating DAPK as a therapeutic target.Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer.Epigenetic alterations in sporadic basal cell carcinomas.The relationship between RASSF1A promoter methylation and thyroid carcinoma: A meta-analysis of 14 articles and a bioinformatics of 2 databases (PRISMA).Active BRAF-V600E is the key player in generation of a sessile serrated polyp-specific DNA methylation profile.DNA methylation analysis for the diagnosis of thyroid nodules - a pilot study with reference to BRAF(V) (600E) mutation and cytopathology results.DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.The Association of BRAF V600E Mutation With Tissue Inhibitor of Metalloproteinase-3 Expression and Clinicopathological Features in Papillary Thyroid Cancer.Multiple Endocrine Neoplasia Syndromes from Genetic and Epigenetic Perspectives.Prior Knowledge Driven Joint NMF Algorithm for ceRNA Co-Module Identification

P2860

Q26866080-A3616AB1-299C-4EDA-BFD0-4C4B8EF1EEFE Q30979720-EE596CDE-7B76-4479-BCCD-37E8E1009E4A Q33562782-E0A91852-9565-4FC4-9F41-8ECAC0538B9F Q33629836-7C71AECE-97F1-4E1B-9E2E-6144D9F35A01 Q33881701-30810BF1-5A77-4E76-AE97-51D94DCBB602 Q34704862-23EE90D4-DDFB-4146-BAD2-A86AE41389BD Q36075869-1AEC4C7D-EA8E-49D9-A7E3-DD62C8CF0D34 Q37585495-D0567158-0CE7-477E-808C-A6F659AF7A66 Q37621631-660F1A08-3DDB-4DCD-9328-CCFFA052674A Q38108825-A38EE6C8-AB2E-44A5-9F9D-FE933FC5CB96 Q38161832-03A7747A-451D-49CE-BDBF-2F5A54F3564F Q38168688-2A6B9840-1C1B-4F72-AA6C-2661ED7E58A9 Q41677197-120DC408-2DAD-4360-B16F-AF7FFD6F211E Q42454854-74BA1D54-0FFB-4C5F-A80F-EF5CDD4CE109 Q47098782-DCA44155-87F3-4F5E-8B35-E524A02A9C0E Q52625681-1D7C5C3C-2B09-4202-AD99-78789E7DA2BA Q53501605-E0E61918-31D2-4107-97E4-D9DD95637DCE Q54387117-2A9624ED-A6FA-45AB-B500-22D5F8270FDF Q55021417-54997ED8-706B-490B-A652-19166715713C Q55712143-117DE575-7473-4A29-B2C5-2E23D42225AF Q59137666-F033002E-D48E-4588-8B3A-9D5F3893468E

P2860

Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer.

http://www.wikidata.org/entity/Q36149220

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Correlation between BRAF mutat ...... and RASSF1A in thyroid cancer.

@ast

Correlation between BRAF mutat ...... and RASSF1A in thyroid cancer.

@en

type

label

Correlation between BRAF mutat ...... and RASSF1A in thyroid cancer.

@ast

Correlation between BRAF mutat ...... and RASSF1A in thyroid cancer.

@en

prefLabel

Correlation between BRAF mutat ...... and RASSF1A in thyroid cancer.

@ast

Correlation between BRAF mutat ...... and RASSF1A in thyroid cancer.

@en

P1433

Q36149220-B13C766C-5A7C-4508-818E-E68F139899ED

P1476

Q36149220-7E51D086-B760-448E-9818-790CF3E9AB19

P2093

Q36149220-3482C963-7C92-4C74-9003-B235D50D53EA

Q36149220-3C8CE70C-130B-472B-BC6A-9A4140B7621C

Q36149220-8DADC25D-0591-424B-A38A-FF37721E5719

Q36149220-8E956CA1-2205-4B88-97B2-C4C3F7B8CD77

Q36149220-9DCAF843-B559-4D9C-8D02-054F1AF4EC98

Q36149220-AB13CD06-51B6-48E9-88CF-B3AF25919464

Q36149220-B9ED660F-F0E4-4E84-965D-7905AA3DEE82

Q36149220-DCA01460-1B29-4FE7-B63F-189BA2CA50EA

Q36149220-E230F315-1ABD-4ED0-9636-0190A0D58D05

P2860

Q36149220-0E23E87F-CC04-4E1B-89CC-E675CB35CD4C

Q36149220-0F41D579-0AA7-454A-8CEE-34AF511279C8

Q36149220-0F958339-3686-4F88-92BE-5D556B3D6152

Q36149220-0FA328BE-DFE7-49D8-8393-1312C07D1D89

Q36149220-12DFD0A3-6654-4A61-92F8-38A26915E14C

Q36149220-17305A4B-1940-46A3-A55D-ECAF701FACE5

Q36149220-1FC076A3-4696-428E-992F-ACD941CF7011

Q36149220-221BE793-0EA0-4D70-A681-63BAE6573D7B

Q36149220-2626045C-7A31-44DF-9E44-7C52B832B49B

Q36149220-2A20E567-3084-4B86-8F1A-11AD6A0F906A

P304

Q36149220-32E26F84-A8DA-47A6-B82D-0B91A2C0FCB7

P31

Q36149220-C5F62637-DA53-41F3-8CDA-659EC5F0E3A4

P356

Q36149220-6EAAC983-A8D7-4D42-B41F-DD13CF160EE9

P433

Q36149220-4E1C0CA1-F98E-4CDA-8A22-3158A4646609

P478

Q36149220-A0726345-0D65-4A86-AF3D-10618D96B6A1

P50

Q36149220-BD06D9E9-6E15-47A4-8FC4-6D0826DAC455

Q36149220-BE4172FC-C986-4DF8-84F3-8A26BEEBE0FA

Q36149220-F10090A2-0F7D-45FA-A11E-4EF3A66C96D4

P577

Q36149220-6F60E24B-754E-4E66-A4D7-0FB7F3E067DE

P5875

Q36149220-36DB03EF-8384-433D-BD1C-397A7DC69A21

P698

Q36149220-35E5A298-7018-4576-9840-6F887907CFBC

P932

Q36149220-28D5A74E-52ED-4827-8441-22882B56E94D

P356

P1433

P1476

Correlation between BRAF mutat ...... and RASSF1A in thyroid cancer.

@en

P2093

Christopher B Umbricht

http://www.w3.org/2001/XMLSchema#string

David Sidransky

http://www.w3.org/2001/XMLSchema#string

Eli Rosenbaum

http://www.w3.org/2001/XMLSchema#string

Kimberly L Ostrow

http://www.w3.org/2001/XMLSchema#string

Marianna Zahurak

http://www.w3.org/2001/XMLSchema#string

Martha Zeiger

http://www.w3.org/2001/XMLSchema#string

Myriam Loyo

http://www.w3.org/2001/XMLSchema#string

Silvana Papagerakis

http://www.w3.org/2001/XMLSchema#string

Steven M Goodman

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1

The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation.

MethyLight: a high-throughput assay to measure DNA methylation

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis

Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis

Identification of a novel Ras-regulated proapoptotic pathway

A gene hypermethylation profile of human cancer

Deletion of p16 and p15 genes in brain tumors

P304

710-719

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/EPI.20524

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Mohammad Obaidul Hoque

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225306263

http://www.w3.org/2001/XMLSchema#string

P698

22694820

http://www.w3.org/2001/XMLSchema#string

P932

3414391

http://www.w3.org/2001/XMLSchema#string